Novartis Bioventures Ltd, 10% Owner at Galera Therapeutics, Inc. (GRTX), sold 25,842 shares at $9.68 ($251K) on 2020-06-02, disclosed to the SEC on 2020-06-04.
Open-market sale of $251k GRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.68 | 5,669 | $55K | 21.9% |
| 2 | $9.68 | 5,669 | $55K | 21.9% |
| 3 | $9.78 | 5,208 | $51K | 20.3% |
| 4 | $9.78 | 5,208 | $51K | 20.3% |
| 5 | $9.55 | 4,088 | $39K | 15.6% |
| Total | $9.70 avg | 25,842 |
| $251K |
| 100% |
| Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |
| ARPO | SELL | 2019-04-10 | $367K | — | Filing → |